




Searching News Database: BioSpecifics Technologies
HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
HSMN NewsFeed - 18 Dec 2008
BioSpecifics Announces Partnership Between Pfizer and Auxilium for XIAFLEX(TM) in Europe
BioSpecifics Announces Partnership Between Pfizer and Auxilium for XIAFLEX(TM) in Europe
HSMN NewsFeed - 20 Nov 2006
Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's Contracture
Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's Contracture
HSMN NewsFeed - 7 Mar 2006
HEALTHPOINT Acquires Collagenase Topical Business from BioSpecifics Technologies Corp.
HEALTHPOINT Acquires Collagenase Topical Business from BioSpecifics Technologies Corp.
Additional items found! 3

Members Archive contains
3 additional stories matching:
BioSpecifics Technologies
(Password required)
BioSpecifics Technologies
(Password required)